Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Ets-1 controls breast cancer cell balance between invasion and growth.

Furlan A, Vercamer C, Bouali F, Damour I, Chotteau-Lelievre A, Wernert N, Desbiens X, Pourtier A.

Int J Cancer. 2014 Nov 15;135(10):2317-28. doi: 10.1002/ijc.28881. Epub 2014 May 5.

2.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

3.

Long interspersed nucleotide acid element-1 ORF-1 protein promotes proliferation and invasion of human colorectal cancer LoVo cells through enhancing ETS-1 activity.

Li MY, Zhu M, Feng F, Cai FY, Fan KC, Jiang H, Wang ZQ, Linghu EQ.

Genet Mol Res. 2014 Apr 14;13(3):6981-94. doi: 10.4238/2014.April.14.13.

4.

Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment.

Furlan A, Vercamer C, Desbiens X, Pourtier A.

J Cell Physiol. 2008 Jun;215(3):782-93. doi: 10.1002/jcp.21360.

PMID:
18181172
5.

RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.

Zhou H, Li J, Zhang Z, Ye R, Shao N, Cheang T, Wang S.

Int J Oncol. 2016 Dec;49(6):2442-2452. doi: 10.3892/ijo.2016.3718. Epub 2016 Oct 5.

PMID:
27748911
6.

HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.

Tan JX, Wang XY, Li HY, Su XL, Wang L, Ran L, Zheng K, Ren GS.

Int J Cancer. 2011 Mar 15;128(6):1303-15. doi: 10.1002/ijc.25460.

7.

Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.

Sin S, Bonin F, Petit V, Meseure D, Lallemand F, Bièche I, Bellahcène A, Castronovo V, de Wever O, Gespach C, Lidereau R, Driouch K.

J Natl Cancer Inst. 2011 Sep 7;103(17):1323-37. doi: 10.1093/jnci/djr290. Epub 2011 Aug 10.

PMID:
21832234
8.

Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.

Fathers KE, Bell ES, Rajadurai CV, Cory S, Zhao H, Mourskaia A, Zuo D, Madore J, Monast A, Mes-Masson AM, Grosset AA, Gaboury L, Hallet M, Siegel P, Park M.

Breast Cancer Res. 2012 May 8;14(3):R74.

9.

PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.

Bartholomeusz C, Gonzalez-Angulo AM, Kazansky A, Krishnamurthy S, Liu P, Yuan LX, Yamasaki F, Liu S, Hayashi N, Zhang D, Esteva FJ, Hortobagyi GN, Ueno NT.

Clin Cancer Res. 2010 Mar 15;16(6):1802-11. doi: 10.1158/1078-0432.CCR-09-1456. Epub 2010 Mar 9.

10.

Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.

Niu Z, Li X, Hu B, Li R, Wang L, Wu L, Wang X.

Acta Biochim Biophys Sin (Shanghai). 2012 Dec;44(12):991-8. doi: 10.1093/abbs/gms091. Epub 2012 Oct 25.

PMID:
23099883
12.

[Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].

Zhang MX, Han N, Yu SY, Leng Y.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):325-9. Chinese.

PMID:
18953828
13.
14.

The FGF-1-specific single-chain antibody scFv1C9 effectively inhibits breast cancer tumour growth and metastasis.

Shi H, Fu C, Wang W, Li Y, Du S, Cao R, Chen J, Sun D, Zhang Z, Wang X, Zhu X.

J Cell Mol Med. 2014 Oct;18(10):2061-70. doi: 10.1111/jcmm.12371. Epub 2014 Aug 15.

15.

Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.

Zhao J, Lu B, Xu H, Tong X, Wu G, Zhang X, Liang A, Cong W, Dai J, Wang H, Wu M, Guo Y.

Hepatology. 2008 Jul;48(1):265-75. doi: 10.1002/hep.22280.

PMID:
18537194
16.

Dipyridamole prevents triple-negative breast-cancer progression.

Spano D, Marshall JC, Marino N, De Martino D, Romano A, Scoppettuolo MN, Bello AM, Di Dato V, Navas L, De Vita G, Medaglia C, Steeg PS, Zollo M.

Clin Exp Metastasis. 2013 Jan;30(1):47-68. doi: 10.1007/s10585-012-9506-0. Epub 2012 Jul 4.

PMID:
22760522
17.

Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner.

Liu ZB, Hou YF, Zhu J, Hu DL, Jin W, Ou ZL, Di GH, Wu J, Shen ZZ, Shao ZM.

Oncogene. 2010 May 20;29(20):2996-3009. doi: 10.1038/onc.2010.70. Epub 2010 Mar 15.

PMID:
20228837
18.

Anti-metastasis activity of black rice anthocyanins against breast cancer: analyses using an ErbB2 positive breast cancer cell line and tumoral xenograft model.

Luo LP, Han B, Yu XP, Chen XY, Zhou J, Chen W, Zhu YF, Peng XL, Zou Q, Li SY.

Asian Pac J Cancer Prev. 2014;15(15):6219-25.

19.

Gene therapy using ets-1 transcription factor decoy for peritoneal dissemination of gastric cancer.

Taniguchi H, Fujiwara Y, Doki Y, Sugita Y, Sohma I, Miyata H, Takiguchi S, Yasuda T, Tomita N, Morishita R, Monden M.

Int J Cancer. 2007 Oct 1;121(7):1609-17.

20.

LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice.

Li R, Doherty J, Antonipillai J, Chen S, Devlin M, Visser K, Baell J, Street I, Anderson RL, Bernard O.

Clin Exp Metastasis. 2013 Apr;30(4):483-95. doi: 10.1007/s10585-012-9553-6. Epub 2012 Dec 13.

PMID:
23239465

Supplemental Content

Support Center